NCT00933985 2014-05-01Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaNational Cancer Institute (NCI)Phase 1 Terminated22 enrolled